Skip to main content
. 2022 Sep 20;10:1018399. doi: 10.3389/fpubh.2022.1018399

Table 1.

Patient clinico-demographic characteristics to study the effect of COVID-19 vaccination on Delta and Omicron nasopharyngeal viral loads.

Characteristic Total (N = 287) SARS-CoV-2 variants
Delta B.1.617.2 Omicron BA.1 Omicron BA.1.1 Omicron BA.2 P-value
Number, n (%) 287 9 (3.1) 50 (17.4) 165 (57.5) 63 (21.9)
Age; years, median (IQR) 73 (64–80) 75 (63–80.5) 71 (59.5–76) 73 (65–81) 72 (65–80) 0.353
Gender; male, n (%) 179 (68.6) 4 (44.4) 36 (72) 110 (66.7) 47 (74.6) 0.256
Viral load, Log10 copies ml−1 5.8 (4.5–6.4) 4.5 (4.2–5.5) 4.7 (3.6–5.8) 6.1 (4.8–6.7) 5.8 (4.8–6.7) <0.0001a
Comorbidities, n (%) 225 (78.4) 8 (88.9) 35 (70) 132 (80) 50 (79.4) 0.399
Vaccination; Yes, n (%) 137 (47.7) 3 (33.3) 29 (58) 71 (43) 34 (54) 0.151
Type of vaccine; n (%)
AZD1222 86 (30) 2 (22.2) 16 (32) 49 (29.7) 19 (30.2) 0.348
BBV152 51 (17.1) 1 (11.1) 12 (24) 24 (14.5) 14 (22.2) 0.255
No. of vaccine doses; n (%)
1 dose 24 (8.4) 1 (11.1) 5 (10) 13 (7.9) 5 (7.9) 0.524
2 doses 113 (39.4) 2 (22.2) 23 (46) 58 (35.2) 30 (47.6) 0.543
Severity; n (%)
Asymptomatic 18 (6.3) 1 (11.1) 4 (8) 9 (5.5) 4 (6.3) 0.849
Mild 87 (30.3) 2 (22.2) 19 (38) 51 (30.9) 15 (23.8) 0.397
Moderate 136 (47.4) 5 (55.6) 22 (4.4) 83 (50.3) 26 (41.3) 0.577
Severe 46 (16) 1 (11.1) 5 (10) 22 (13.3) 18 (28.6) 0.021*
Medical support; n (%)
Hospitalization 285 (99.3) 9 (100) 50 (100) 164 (99.4) 62 (98.4) 0.764
HDU/ICU 122 (42.5) 4 (44.4) 25 (50) 76 (46.1) 15 (23.8) 0.021*
O2 support 120 (41.8) 4 (44.4) 25 (50) 77 (46.7) 16 (25.4) 0.021*
Ventilator 34 (11.8) 2 (22.2) 9 (18) 20 (12.1) 3 (4.8) 0.123
Death; n (%) 237 (82.6) 8 (88.9) 31 (62) 140 (84.8) 58 (92.1) <0.0001****
Day to death; day, median (IQR) 3 (1–6) 5.5 (2.5–15.3) 3 (2–6) 3 (1–6) 4 (2–6.3) 0.163

All data reported as numbers (n) and percentages (%) unless specified. HDU, High dependency unit; IQR, interquartile range; ICU, intensive care unit; O2, Oxygen. *, **, ***, **** represent P <0.05, <0.01, <0.001 and <0.0001, respectively.

represent comparisons was made between different variants of SARS-CoV-2.